| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 74,568 | 75,648 | 78,323 | 81,956 | | Cost of Revenue | 25,169 | 24,380 | 26,130 | 27,716 | | | Gross Profit | 49,399 | 51,268 | 52,193 | 54,240 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,370 | 7,610 | 7,229 | 4,897 | | Non Recurring | (3,088) | 3,088 |
-
|
-
| | Others | 23,461 | 17,511 | 24,348 | 22,617 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 22,656 | 23,059 | 20,616 | 26,726 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 736 | 471 | 457 | 387 | | Earnings Before Interest And Taxes | 22,633 | 22,804 | 20,716 | 26,548 | | Interest Expense | 20,610 | 19,773 | 19,340 | 20,299 | | Income Before Tax | 2,023 | 3,031 | 1,376 | 6,249 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 191 | 107 | 281 |
-
| | | | Net Income From Continuing Ops | 2,214 | 3,138 | 1,657 | 6,249 | | | Non-recurring Events | | Discontinued Operations | (289) | (107) | (853) | (167) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,925 | 3,031 | 804 | 6,082 | | Preferred Stock And Other Adjustments | (4,360) | (4,359) | (4,359) | (4,359) | | | Net Income Applicable To Common Shares | ($2,435) | ($1,328) | ($3,555) | $1,723 |
|
0.51% Nasdaq 
Income Statement
